Abstract. Steroidogenic factor-1 (SF-1) regulates the transcription of multiple genes involved in the androgen biosynthesis, and SF-1 Gly146Ala polymorphism is known to reduce the transactivation function by ~20%. To examine whether the Gly146Ala polymorphism constitutes a susceptibility factor for the development of micropenis (MP), we analyzed this polymorphism in a total of 52 patients with micropenis (T-MP) consisting of 30 patients with severe MP below -2.5 SD (S-MP) and 22 patients with mild MP from -2.1 SD to -2.5 SD (M-MP), together with 115 control males. The Ala allele, the Ala/Gly genotype, and the Ala/Ala plus Ala/Gly genotype frequencies were significantly higher in the S-MP patients than in the control males, whereas the allele and the genotype frequencies were comparable between the M-MP patients and the control males. The results suggest that the SF-1 Gly146Ala polymorphism may constitute a susceptibility factor for the development of S-MP, and that M-MP can be regarded as a normal variation in terms of the polymorphism effect.
MICROPENIS (MP) is a heterogeneous condition defined as significantly small penis without associated external genital ambiguity such as hypospadias [1, 2] . It is a common ailment and can take place as an isolated form or as a part of impaired male sex development [1, 2] . While MP with other genital features often results from single gene abnormalities, apparently isolated MP, though it still can be caused by single gene abnormalities in rare cases [3, 4] , usually occurs as a multifactorial trait subject to various relatively minor genetic and environmental factors [1, 2] . In this regard, since penile growth is primarily caused by the androgen action, hypofunctional polymorphism of a gene(s) involved in the androgen effect may raise susceptibility to the development of MP.
Steroidogenic factor-1 (SF-1) is an orphan nuclear receptor that was initially identified as a key determinant of steroid hormone biosynthesis [5] . Subsequent studies have shown that SF-1 regulates the transcription of a vast array of genes relevant to adrenal and gonadal development, sex differentiation, steroidogenesis, and reproduction [5] . In this context, WuQiang et al. [6] have reported that Gly146Ala polymorphism at exon 4 reduces the SF-1 transactivation function for the adrenal specific cyp11A promoter and the ovary specific cyp19 promoter II by ~20%. It may be possible, therefore, that the Gly146Ala polymorphism also decreases the transcription of genes involved in the androgen production, raising the susceptibility to MP. In addition, since SF-1 is involved in the rescue of androgen-mediated suppression of the bovine LHb promoter through protein-protein interactions with androgen receptor (AR) [7, 8] , SF-1 protein with the Ala residue may attenuate LHb transcription, contributing to the development of MP. Thus, we analyzed the polymorphism in patients with MP and in control males, to examine whether the Gly146Ala polymorphism constitutes a susceptibility factor for MP.
Materials and Methods

Subjects
This study consisted of 52 Japanese prepubertal patients with MP aged 0-13 yr (median 7 yr). Since -2.5 SD and -2.0 SD have been used as the lower limit of normal penile lengths [1, 2] , the total of 52 MP patients (T-MP) were divided into two groups: 30 patients with severe MP below -2.5 SD (S-MP) and 22 patients with mild MP from -2.1 SD to -2.5 SD (M-MP), on the basis of penile length assessment by the age-matched Japanese reference data [9] . All the patients satisfied the following selection criteria: (1) lack of other discernible genital and extragenital features, including hypospadias; (2) 46, XY karyotype in all the ³20 lymphocytes analyzed; (3) no demonstrable mutation of SRD5A2 for 5a-reductase-2 [3] and AR [4] that can affect male genital development; (4) lack of significant difference in the allele and genotype frequencies of Val89Leu polymorphism at exon 1 of SRD5A2 [3] that is known to reduce the 5a-reductase-2 activity by ~30% [10] ; (5) no significant expansion of CAG repeat length at exon 1 of AR [4] that is known to raise the susceptibility to undermasculinization [11] ; and (6) age-appropriate basal serum gonadotropin and testosterone values, except for apparently low FSH levels in a 7-year-old boy with S-MP (<0.2 mIU/mL) and in a 9-year-old boy with M-MP (0.2 mIU/mL). For controls, 115 Japanese adult males with proven fertility aged 25-48 yr (median 38.5 yr) were utilized with permission.
Gly146Ala polymorphism analysis
The Gly146Ala polymorphism was examined by the restriction enzyme digestion method [6] . In brief, leukocyte genomic DNA of each subject was amplified by polymerase chain reaction (PCR) with primers flanking exon 4, and the PCR products were digested with SphI. The primer sequences used were 5'-CTT AGAGAGGGTGAGTCTGA-3' (forward) and 5'-CT GAAGCCAGTGGGAAGGAT-3' (reverse), and the annealing temperature was 60°C. The PCR products harbor a polymorphism dependent SphI site where the Gly allele is undigested and the Ala allele is digested with SphI. Thus, the SphI digestion yields one 773 bp fragment for the Gly allele and two 541 bp and 232 bp fragments for the Ala allele, thereby discriminating the polymorphism. Furthermore, to examine the accuracy of the SphI digestion, direct sequencing was performed on a CEQ 8000 autosequencer (Beckman Coulter, Fullerton, CA) for five PCR products per each of the Ala/Ala, the Ala/Gly, and the Gly/Gly genotypes assessed by the enzyme digestion method. This study has been approved by the Institutional Review Board Committees at National Center for Child Health and Development and Keio University Hospital.
Statistical analysis
Statistical significance of the difference in allele and genotype frequencies was analyzed by c 2 test using R environment for statistical computing (http://www. r-project.org/). The odds ratio and the 95% confidence interval were calculated using the same environment.
Results
The results of polymorphism analysis are shown in the left half of Table 1 . The data obtained by the enzyme digestion method were consistent with those indicated by the direct sequencing method, in all the PCR products examined. Remarkably, the Ala/Gly genotype was the most prevalent genotype in the S-MP patients, while it was much lower in prevalence than the Gly/Gly genotype in the control males as well as in the M-MP patients.
The results of statistical analysis are summarized in the right half of Table 1 . The Ala allele, the Ala/Gly genotype, and the Ala/Ala plus Ala/Gly genotype frequencies were significantly higher in the S-MP patients than in the control males, while the Ala/Ala vs. Ala/ Gly plus Gly/Gly genotype frequency was comparable between the two groups. By contrast, the allele and the genotype frequencies were comparable between the M-MP patients and the control males. Consequently, the difference in the allele and the genotype frequencies became less or not significant between the T-MO patients and the control males.
Discussion
The Ala/Gly genotype heterozygous for the Ala allele was frequently identified in the S-MP patients and, consistent with this, the Ala allele, the Ala/Gly genotype, and the Ala/Ala plus Ala/Gly genotype were more prevalent in the S-MP patients than in the control males. This would suggest that the Gly146Ala polymorphism forms a dominant susceptibility factor for the development of S-MP. In this context, variation in other genetic and environmental factors would determine whether individuals with the Ala allele have S-MP or not. Furthermore, the statistical significance of the allele and genotype frequencies was higher between the S-MP patients and the control males than between the T-MP patients and the control males, although the number of analyzed patients was smaller for S-MP than for T-MP. Since more significant results were obtained after the selection of patients with more definite phenotype, this would provide further support for the relevance of the Gly146Ala polymorphism to the development of S-MP.
By contrast, the allele and genotype frequencies were comparable between the M-MP patients and the control males. This may imply that M-MP is to be regarded as a normal variation rather than a pathologic phenotype in terms of the Gly146Ala polymorphism effect. Indeed, the definition of MP is artificial rather than biological and, empirically, -2.5 SD rather than -2.0 SD is frequently utilized as the lower limit of normal penile length [1] . However, since the Gly146Ala polymorphism is likely to act as a susceptibility factor, the Gly146Ala polymorphism may have been detected as a positive modifying factor in the S-MP patients but not in the M-MP patients just by chance. For example, the expansion of CAG repeat lengths of AR, that is associated with a reduced AR function [12] , has been identified as a positive susceptibility factor for spermatogenic failure in some patient populations but not in other patient populations [13, 14] . In addition, we have previously reported the positive association of both S-MP and M-MP with the Pro185Ala polymorphism in the gene for aryl hydrocarbon receptor repressor that negatively regulates the dioxin-related signaling [15] . Thus, further studies are necessary to examine this issue.
The association of S-MP with the Gly146Ala polymorphism would be consistent with the previous report that this polymorphism reduces the SF-1 transcription activity by ~20% [6] . One may wonder whether such mild hypofunction of the Ala allele, which appears in a heterozygous condition in most patients, can actually constitute a susceptibility factor for S-MP, because the Val89Leu polymorphism of SRD5A2 that reduces the 5a-reductase activity by ~30% [8] has been shown to be irrelevant to the development of both S-MP and M-MP in the patients examined here [3] . However, SF-1 is known to regulate the androgen biosynthesis at multiple steps including gonadotropin secretion, testicular steroidogenesis, and testis development [5] , and heterozygous amorphic mutations (haploinsufficiency) as well as a heterozygous dominant negative mutation and a homozygous hypomorphic mutation have been identified in SF-1 of patients with severe disease phenotype such as XY sex reversal [reviewed in ref. 16 ]. Thus, such a mild hypofunction of the Ala allele appears to be compatible with the polymorphism being relevant to the S-MP only phenotype. Furthermore, MP is well explained as the consequence of gonadotropin deficiency in the middle to late fetal life [1, 2] , and the interaction between SF-1 and AR proteins is relevant to the rescue of androgen-mediated suppression of the bovine LHb promoter [7, 8] . Thus, the polymorphism may influence the SF-1 and AR protein interactions, contributing to the development of MP. In this context, since the individuals with the Ala allele lacked other genital abnormalities such as hypospadias as well as adrenal failure, this may suggest that the effects of the polymorphism are insufficient to cause such phenotype. In summary, the results suggest that the SF-1 Gly146Ala polymorphism may constitute a susceptibility factor for the development of S-MP. However, the patients examined are still small in number, and some of them may have an unidentified pathologic cause(s) for S-MP, such as hypogonadotropic hypogonadism that is usually diagnosed in the pubertal period. Thus, further studies are necessary to examine the validity of this notion.
